Menopause associated with increased prevalence of cardiovascular autonomic neuropathy in women with diabetes: this study

Published Date: 02 Mar 2023

Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...

Read Full News

Latest News

Levothyroxine Discontinuation Safe for Many Older Adults

About 1 in 4 overall and two thirds of those taking doses of 50 µg/d or lower were able to come off the treatment while maintaining adequate thyroid function for 1 year.

Nuanced Sexual and Pelvic Floor Effects of GLP-1s on Women

Emerging research and anecdotal reports suggest that the weight-loss drugs may cause vulvar and urogenital changes.

Patients With Acromegaly Have Higher Risk for Cancer

Patients with acromegaly show a significantly higher risk for cancer than matched control individuals from the general population, with the risk being evident even 5 years before diagnosis.

APHRODITE Model May Improve Care in Male Infertility

A new classification framework introduces structured phenotyping to guide hormonal therapy in male infertility, addressing long-standing reliance on empirical treatment approaches.

Novo Nordisk Launches Higher-dose Wegovy in the United States

Novo Nordisk said on Tuesday that it has made ⁠a higher-dose version of its blockbuster weight-loss drug Wegovy ⁠available across the United States.

Weight Loss After Tirzepatide Varies by Prior Weight Change

Tirzepatide produced notable weight loss in real-world settings, but patients with prior weight loss experienced smaller additional reductions than those without.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

About 1 in 4 overall and two thirds of those taking doses of 50 µg/d or lower were able to come off the treatment while maintaining adequate thyroid function for 1 year.

Emerging research and anecdotal reports suggest that the weight-loss drugs may cause vulvar and urogenital changes.

Patients with acromegaly show a significantly higher risk for cancer than matched control individuals from the general population, with the risk being evident even 5 years before diagnosis.

A new classification framework introduces structured phenotyping to guide hormonal therapy in male infertility, addressing long-standing reliance on empirical treatment approaches.

Novo Nordisk said on Tuesday that it has made ⁠a higher-dose version of its blockbuster weight-loss drug Wegovy ⁠available across the United States.

Tirzepatide produced notable weight loss in real-world settings, but patients with prior weight loss experienced smaller additional reductions than those without.

News All Time

Sugar Tax Debate Intensifies as Health Evidence Builds

Evidence suggests that sugar taxes may influence obesity patterns among younger populations.

Airline Websites Vary on Info for Passengers With Obesity

Across 50 leading airlines globally, all offer some content for passengers with obesity, but the specifics vary widely.

Gene Therapy to Be Studied for Treating Type 1 Diabetes

A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success

Viridian Therapeutics' experimental treatment for thyroid eye ⁠disease lagged rivals in efficacy in a late-stage...

Beyond Diabetes Control: Tirzepatide Boosts Quality of Life

Switching to tirzepatide yields greater quality-of-life benefits than increasing the dulaglutide dose in patients with type 2 diabetes.

BMI Misclassifies Many Adults With Obesity

Researchers using the gold-standard DEXA to measure body fat percentage showed that BMI misclassified a notable proportion of adults, placing many in incorrect weight categories.

Novo Nordisk Cuts Ozempic, Wegovy Prices in India Again to Fight Cheaper Generics

Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and ⁠48% in India, to fend off competition from...

Tirzepatide Boosts Metabolic Health in Partial Lipodystrophy

Tirzepatide significantly improves metabolic health and reduces insulin dependence in patients with partial lipodystrophy.

EMA Clears New First-Line Options for Advanced Cancers

European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.

NICE Introduces Endometriosis Fertility Pathway

An updated NICE guideline sets out a dedicated pathway for endometriosis within wider fertility guidance.

Weight Loss May Cut Cancer Risk in Adults With Obesity

Nonsurgical weight loss is associated with reduced incident risks for both obesity-related and other cancers in adults with obesity.

Medtronic Gets US FDA Nod to Use Surgical System in Cranial, ENT Surgeries

Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system ⁠for cranial and ear, nose and throat procedures, expanding the platform...

EU Reaffirms Rejection of Rare Sleep Disorder Drug

The sleep drug failed to gain approval for nighttime disruptions in children with a rare genetic disorder affecting circadian rhythm patterns.

Experts Question Evidence for New Testosterone Advice

New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.

Once- or Twice-Yearly Injection for Weight Loss?

Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

Do ESAs for Anemia Raise Cancer Risk in Dialysis Patients?

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

Recommended News For You

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

We Don't Always Know What's 'Best' for Our Patients

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

Early palliative care billing up from 2010 to 2019 for advanced cancer

Recommended Articles For You

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options  

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment 

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy 

Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alkem introduces cetuximab under the trade name Cetuxa in India.

2.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

3.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

4.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

5.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

1.

Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy

2.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

3.

A Visual Guide to Understanding Breast Cancer Staging

4.

CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review

5.

Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

3.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

4.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

5.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot